Insilico’s AI-driven IPF candidate rentosertib shows potential for biological age reversal, as assessed by six proteomic aging clocks: Cambridge, Massachusetts Tuesday, Septembe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results